Quest Partners LLC Pacira Bio Sciences, Inc. Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 19,520 shares of PCRX stock, worth $498,931. This represents 0.05% of its overall portfolio holdings.
Number of Shares
19,520
Previous 13,493
44.67%
Holding current value
$498,931
Previous $254 Million
90.82%
% of portfolio
0.05%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$205 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$134 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$57.9 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$57.3 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$52.4 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.17B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...